Dr. Luisa Imberti was a senior researcher at the Clinical Chemistry Section, Main Hospital of Brescia, Italy. She received her degree in Medicine and Surgery from the University of Milan, Italy, in 1981. Her postgraduate specialization in 1991 was in Biochemistry, and in 2001 in Allergology and Clinical Immunology from the University of Brescia, Italy. Her main research activity is in the field of translational research, with a special contribution in the biology and management of primary and secondary human immunodeficiencies, in the pathogenesis of multiple sclerosis and, recently, of COVID-19.